Results of a Phase I Clinical Safety Trial using a child’s own cord blood were recently published, and are giving families and researchers hope. Read More
Duke University Medical Center is currently conducting a Phase II clinical research trial using a cord blood infusion for children with Autism Spectrum Disorder (ASD). The goal of the study is to to determine if there is a benefit from an intravenous infusion of autologous (the child’s own) or unrelated donor cord blood to children with ASD.
This clinical trial offers hope for families affected with ASD, and over a dozen ViaCord families have requested access to their banked cord blood in order to participate in the clinical research trial. Read More
Autism, a disorder that appears in the first three years of life, affects the brain’s development and impacts social and communication skills.1 While the exact causes of Autism Spectrum Disorder (ASD) are unknown, research suggests that both genes and environment play important roles.2 Read More